Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Acta Pharmaceutica Sinica ; (12): 2642-2653, 2022.
Article in Chinese | WPRIM | ID: wpr-941518

ABSTRACT

In recent years, the oceans have provided an important source of highly promising new anti-tumor drugs for innovation and screening, with approximately 56% of biologically active compounds being discovered to have anti-tumor effects each year. In this study, we classified and summarized the approved drugs of marine origin in terms of anti-tumor therapy, and firstly, we briefly overviewed the role of the immune system in cancer pathogenesis and discussed the current dilemma of cancer immunotherapy and highlighted the main anti-tumor targets of marine drugs. Further, with a focus on tumor immunity, we classified and outlined the history of currently approved marine original drugs by species origin, structural features, relevant pathways, and clinical application and therapy. Lastly, the limitations of current marine drug research were discussed, as well as prospects and trends in new drug development.

2.
Chinese Journal of Surgery ; (12): E002-E002, 2020.
Article in Chinese | WPRIM | ID: wpr-787675

ABSTRACT

The novel coronavirus pneumonia (NCP) has cost a great loss to the health and economic property of Chines people. Under such a special circumstance, how to deal with such patients with acute aortic syndrome has become a serious challenge. Rapid diagnosis of concomitant NCP, safe and effective transportation, implementation of the interventional procedure, protection of vascular surgical team and postoperative management and follow-up of such patients have become urgent problems for us. Combined with the latest novel government documents, the literature and the experiences from Wuhan, we answered the above questions briefly and plainly. It also hopes to inspire the national vascular surgeons to manage critical emergencies in vascular surgery and even routine vascular diseases with NCP, as a final point to limit the severe epidemic situation, and minimize the damage of NCP.

3.
Chinese Journal of Contemporary Pediatrics ; (12): 635-638, 2016.
Article in Chinese | WPRIM | ID: wpr-261176

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the influence of delayed cord clamping (DCC) on preterm infants with a gestational age of <32 weeks.</p><p><b>METHODS</b>Ninety preterm infants with a gestational age of <32 weeks delivered naturally from January to December, 2015 were enrolled and randomly divided into DCC group (46 infants) and immediate cord clamping (ICC) group (44 infants). The routine blood test results, total amount of red blood cell transfusion, blood gas parameters, mean arterial pressure, bilirubin peak, total time of phototherapy, and incidence rates of necrotizing enterocolitis, late-onset sepsis, intracranial hemorrhage, retinopathy, and bronchopulmonary dysplasia were compared between the two groups.</p><p><b>RESULTS</b>Compared with the ICC group, the DCC group had significantly higher levels of hemoglobin, hematocrit, mean arterial pressure, and standard base excess (P<0.05), as well as a significantly lower percentage of preterm infants who underwent volume expansion and dopamine treatment and a significantly lower amount of red blood cell transfusion (P<0.05). The body temperature, pH value, HCO3(-) concentration, serum bilirubin peak, total time of phototherapy, and incidence rates of late-onset sepsis, retinopathy, grade≥2 intracranial hemorrhage, and grade≥2 neonatal necrotizing enterocolitis showed no significant differences between the two groups (P>0.05).</p><p><b>CONCLUSIONS</b>DCC is a safe clinical intervention and can improve the prognosis of preterm infants with a gestational age of <32 weeks.</p>


Subject(s)
Female , Humans , Infant, Newborn , Male , Constriction , Delivery, Obstetric , Methods , Gestational Age , Blood , Infant, Premature , Time Factors , Umbilical Cord
4.
Chinese Journal of Medical Genetics ; (6): 449-452, 2010.
Article in Chinese | WPRIM | ID: wpr-234385

ABSTRACT

<p><b>OBJECTIVE</b>To establish a multiplex real-time quantitative PCR method for diagnosis of Down's and Edward's syndrome.</p><p><b>METHODS</b>The sequences of the amyloid precursor protein gene (APP) in the Down's region of chromosome 21 and the thymidylate synthetase gene (TYMS) on chromosome 18 were co-amplified in the same tube. The relative quantitative index DeltaCT value was used to differentiate Down's and Edward's syndrome patient from healthy individual. Four groups of samples, including 36 blood samples from normal controls (group A), 15 amniotic fluid samples from normal pregnancies (group B), 21 samples from patients with Down's syndrome (group C) and 6 samples from patients with Edward's syndrome (group D), were investigated in the study.</p><p><b>RESULTS</b>The mean DeltaCT values of the four groups were -0.48+/-0.15, -0.49+/-0.12, -1.26+/-0.17 and 0.25+/-0.12 respectively. The DeltaCT value from group B was not different from that from group A (P>0.05). However, the DeltaCT values from group C and group D were significantly different from that from group A (P<0.01), and no overlapping was observed.</p><p><b>CONCLUSION</b>The DeltaCT values from multiplex real-time quantitative PCR could be used to rapidly diagnose Down's and Edward's syndrome simultaneously.</p>


Subject(s)
Female , Humans , Pregnancy , Amniotic Fluid , Chromosomes, Human, Pair 18 , Genetics , Chromosomes, Human, Pair 21 , Genetics , Down Syndrome , Genetics , Polymerase Chain Reaction , Prenatal Diagnosis , Methods , Syndrome , Trisomy
SELECTION OF CITATIONS
SEARCH DETAIL